EA200600860A1 - Производные n-тиазол-2-илбензамида - Google Patents

Производные n-тиазол-2-илбензамида

Info

Publication number
EA200600860A1
EA200600860A1 EA200600860A EA200600860A EA200600860A1 EA 200600860 A1 EA200600860 A1 EA 200600860A1 EA 200600860 A EA200600860 A EA 200600860A EA 200600860 A EA200600860 A EA 200600860A EA 200600860 A1 EA200600860 A1 EA 200600860A1
Authority
EA
Eurasian Patent Office
Prior art keywords
thiazol
derivatives
ilbenzamide
agonists
receptor
Prior art date
Application number
EA200600860A
Other languages
English (en)
Other versions
EA010790B1 (ru
Inventor
Аннете Гравен Самс
Могенс Ларсен
Гитте Миккельсен
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Publication of EA200600860A1 publication Critical patent/EA200600860A1/ru
Publication of EA010790B1 publication Critical patent/EA010790B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Изобретение относится к производным N-тиазол-2-илбензамида формулы I, представленной в описании, переменные в которой определены в формуле изобретения. Соединения являются лигандами рецептора A, такими как антагонисты, агонисты, обратные агонисты или частичные агонисты, и полезны при лечении неврологических и психиатрических расстройств, в которые вовлечен рецептор A.
EA200600860A 2003-10-27 2004-10-25 Производные n-тиазол-2-илбензамида EA010790B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200301579 2003-10-27
DKPA200400229 2004-02-13
PCT/DK2004/000733 WO2005039572A1 (en) 2003-10-27 2004-10-25 N-thiazol-2-yl-benzamide derivatives

Publications (2)

Publication Number Publication Date
EA200600860A1 true EA200600860A1 (ru) 2006-08-25
EA010790B1 EA010790B1 (ru) 2008-10-30

Family

ID=34524309

Family Applications (2)

Application Number Title Priority Date Filing Date
EA200801734A EA200801734A1 (ru) 2003-10-27 2004-10-25 Производные n-тиазол-2-илбензамида
EA200600860A EA010790B1 (ru) 2003-10-27 2004-10-25 Производные n-тиазол-2-илбензамида

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA200801734A EA200801734A1 (ru) 2003-10-27 2004-10-25 Производные n-тиазол-2-илбензамида

Country Status (28)

Country Link
US (2) US20060154974A1 (ru)
EP (2) EP1803455A1 (ru)
JP (1) JP2007509083A (ru)
KR (1) KR20060093726A (ru)
AR (1) AR047621A1 (ru)
AT (1) ATE354365T1 (ru)
AU (1) AU2004283019A1 (ru)
BR (1) BRPI0415661A (ru)
CA (1) CA2542816A1 (ru)
CO (1) CO5690582A2 (ru)
CY (1) CY1106526T1 (ru)
DE (1) DE602004004925T2 (ru)
DK (1) DK1682129T3 (ru)
EA (2) EA200801734A1 (ru)
ES (1) ES2279414T3 (ru)
HR (1) HRP20070194T3 (ru)
IL (1) IL175189A0 (ru)
IS (1) IS8364A (ru)
ME (1) MEP6708A (ru)
MX (1) MXPA06004436A (ru)
NO (1) NO20062417L (ru)
PL (1) PL1682129T3 (ru)
PT (1) PT1682129E (ru)
RS (1) RS20060289A (ru)
SG (1) SG147472A1 (ru)
SI (1) SI1682129T1 (ru)
TW (1) TW200524887A (ru)
WO (1) WO2005039572A1 (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060106040A1 (en) 2002-12-19 2006-05-18 Michael Grzelak Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
TW200524887A (en) * 2003-10-27 2005-08-01 Lundbeck & Co As H N-thiazol-2-yl-benzamide derivatives
WO2006032273A1 (en) 2004-09-22 2006-03-30 H. Lundbeck A/S 2-acylaminothiazole derivatives
US7674912B2 (en) 2005-04-25 2010-03-09 H. Lundbeck A/S Pro-drugs of N-thiazol-2-yl-benzamide derivatives
TW200720264A (en) * 2005-04-25 2007-06-01 Lundbeck & Co As H Pro-drugs of n-thiazol-2-yl-benzamide derivatives
WO2006137527A1 (ja) 2005-06-23 2006-12-28 Kyowa Hakko Kogyo Co., Ltd. チアゾール誘導体
SI1921077T1 (sl) * 2005-08-02 2017-11-30 Kyowa Hakko Kirin Co., Ltd. Sredstvo za zdravljenje in/ali preprečevanje motnje spanja
ES2273599B1 (es) 2005-10-14 2008-06-01 Universidad De Barcelona Compuestos para el tratamiento de la fibrilacion auricular.
EP2210891A1 (en) * 2009-01-26 2010-07-28 Domain Therapeutics New adenosine receptor ligands and uses thereof
GB201106817D0 (en) 2011-04-21 2011-06-01 Astex Therapeutics Ltd New compound
RU2483722C1 (ru) * 2012-05-22 2013-06-10 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Аминотиазольные производные усниновой кислоты как новые противотуберкулезные агенты
GB201218864D0 (en) 2012-10-19 2012-12-05 Astex Therapeutics Ltd Bicyclic heterocycle compounds and their uses in therapy
GB201218850D0 (en) 2012-10-19 2012-12-05 Astex Therapeutics Ltd Bicyclic heterocycle compounds and their uses in therapy
US9980973B2 (en) 2012-10-19 2018-05-29 Astex Therapeutics Limited Bicyclic heterocycle compounds and their uses in therapy
GB201218862D0 (en) 2012-10-19 2012-12-05 Astex Therapeutics Ltd Bicyclic heterocycle compounds and their uses in therapy
CN105829310B (zh) 2013-12-20 2019-04-12 阿斯特克斯治疗有限公司 双环杂环化合物及其治疗用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE855120C (de) * 1950-10-08 1953-01-05 Schering Ag Verfahren zur Herstellung von Aminosalicylsaeureamiden
JP2903339B2 (ja) * 1990-10-12 1999-06-07 大日精化工業株式会社 電子写真感光体
ATE231137T1 (de) * 1996-10-24 2003-02-15 Zeria Pharm Co Ltd Substituierte benzoylthiazolderivate und sie enthaltende medikamente
GB9823871D0 (en) * 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
GB0028383D0 (en) * 2000-11-21 2001-01-03 Novartis Ag Organic compounds
US20040063764A1 (en) * 2001-01-26 2004-04-01 Hiroshi Takemoto Halogen compounds having thrombopoietin receptor agonism
US7429593B2 (en) * 2001-09-14 2008-09-30 Shionogi & Co., Ltd. Utilities of amide compounds
US6624163B2 (en) * 2001-11-29 2003-09-23 Hoffman-La Roche Inc. Benzothiazole derivatives
US6713499B2 (en) * 2001-12-12 2004-03-30 Hoffman-La Roche Inc. 7-Amino-benzothiazole derivatives
TW200524887A (en) * 2003-10-27 2005-08-01 Lundbeck & Co As H N-thiazol-2-yl-benzamide derivatives
EA013249B1 (ru) * 2003-12-26 2010-04-30 Киова Хакко Кирин Ко., Лтд. Производные тиазола
US7674912B2 (en) * 2005-04-25 2010-03-09 H. Lundbeck A/S Pro-drugs of N-thiazol-2-yl-benzamide derivatives

Also Published As

Publication number Publication date
US20090247593A1 (en) 2009-10-01
ES2279414T3 (es) 2007-08-16
SG147472A1 (en) 2008-11-28
EP1682129B1 (en) 2007-02-21
DK1682129T3 (da) 2007-06-11
WO2005039572A1 (en) 2005-05-06
BRPI0415661A (pt) 2006-12-19
MXPA06004436A (es) 2006-06-20
IS8364A (is) 2006-03-20
AU2004283019A1 (en) 2005-05-06
DE602004004925T2 (de) 2007-10-31
PL1682129T3 (pl) 2007-07-31
CO5690582A2 (es) 2006-10-31
IL175189A0 (en) 2006-09-05
SI1682129T1 (sl) 2007-06-30
EA200801734A1 (ru) 2008-12-30
HRP20070194T3 (en) 2007-06-30
DE602004004925D1 (de) 2007-04-05
US20060154974A1 (en) 2006-07-13
MEP6708A (xx) 2010-02-10
KR20060093726A (ko) 2006-08-25
ATE354365T1 (de) 2007-03-15
CY1106526T1 (el) 2012-01-25
EA010790B1 (ru) 2008-10-30
JP2007509083A (ja) 2007-04-12
TW200524887A (en) 2005-08-01
RS20060289A (en) 2008-06-05
EP1803455A1 (en) 2007-07-04
EP1682129A1 (en) 2006-07-26
CA2542816A1 (en) 2005-05-06
PT1682129E (pt) 2007-04-30
AR047621A1 (es) 2006-02-01
NO20062417L (no) 2006-05-26

Similar Documents

Publication Publication Date Title
EA200600860A1 (ru) Производные n-тиазол-2-илбензамида
EA200301073A1 (ru) N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора
ATE466860T1 (de) Cgrp-rezeptorantagonisten
SE0202241D0 (sv) Novel Compounds
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
TW200505903A (en) CGRP receptor antagonists
CY1108703T1 (el) Αλλοστερικοι ρυθμιστες μεταβολοτροπων υποδοχεων γλουταμικου
EA200300829A1 (ru) Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6
ATE503755T1 (de) Cgrp-rezeptorantagonisten
GB0510143D0 (en) Novel compounds A1
ATE537170T1 (de) Cgrp-rezeptorantagonisten
MXPA05007115A (es) Nuevos agonistas inversos del receptor cb 1.
ATE507880T1 (de) Cgrp-rezeptorantagonisten
ATE467636T1 (de) Pyrazoloä3 , 4-düazepinderivate als histamin-h3- antagonisten
EA200301143A1 (ru) Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6
NO20072060L (no) 2-acylaminotiazolderivater
CY1108837T1 (el) ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5
BG105710A (en) 5ht1 antagonists for antidepressant therapy
ATE346040T1 (de) Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit
GB0103045D0 (en) Organic Compounds
EA200300179A1 (ru) Производные индола для лечения заболеваний цнс
EA200600416A1 (ru) Производные циклопропила в качестве антагонистов рецептора nk3
EA200970573A1 (ru) Агенты, усиливающие действие амра-рецепторов
ATE383343T1 (de) Imidazolderivate verwendbar als histamin h3 rezeptorliganden
EA200702332A1 (ru) Пролекарства n-тиазол-2-илбензамидных производных

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU